Your session is about to expire
← Back to Search
Cancer Preventive Agent
Soy Isoflavones for Cancer Prevention
N/A
Waitlist Available
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial will study the effects of different amounts and types of soy isoflavones on the risk of cancer.
Who is the study for?
This trial is for healthy men and women aged 18 or older who have not consumed soy protein in the past week. Participants should not have chronic liver, kidney, heart, or lung diseases and must not be allergic to soy proteins.Check my eligibility
What is being tested?
The study aims to find out the most effective amount and type of dietary soy isoflavones that could help prevent cancer. Isoflavones are natural compounds found in soy foods believed to reduce cancer risk.See study design
What are the potential side effects?
Since this trial involves dietary supplements from common foods (soy), side effects may be minimal but can include digestive discomfort or allergic reactions in those sensitive to soy products.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
Children's Hospital Medical Center, CincinnatiLead Sponsor
815 Previous Clinical Trials
6,531,501 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,662 Previous Clinical Trials
40,925,791 Total Patients Enrolled
Kenneth Setchell, PhDStudy ChairChildren's Hospital Medical Center, Cincinnati
2 Previous Clinical Trials
138 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older and in good health.My treatment plan does not specify surgery.My treatment plan does not specify radiotherapy.I have a long-term lung condition.I have a long-term heart condition.I have not taken antibiotics in the last 3 months.I am currently on hormone therapy, such as birth control pills or hormone replacement.I have a long-term liver condition.My blood cell levels have not been specified.I am not on medication that affects my stomach, liver, or kidneys.I have long-term kidney disease.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Would this research endeavor be open to welcoming additional participants at present?
"Clinicaltrials.gov states that this trial, which was first posted on October 1st 1996 and last updated on December 18th 2013, is no longer inviting individuals to take part in it. However, 41 other medical studies are currently enrolling patients."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger